Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Women & Infants Hospital of Rhode Island gives first 3D Mammograms in the region

| . DOTmed::Language=HASH(0x56539745ae40)->translator()->translate(text=>'An Interview with') .qq| Michael Johns of DOTmed.com, Inc. | August 07, 2013
Womens & Infants
DOTmed: Tell us about this purchase.
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & Infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.

Women & Infants is the first and only facility in southeastern New England to offer this new technology, which was approved in February 2011 by the federal Food and Drug Administration (FDA). The first woman to receive a digital tomosynthesis test in the region was processed at the hospital yesterday.

Digital breast tomosynthesis captures three-dimensional images of the breast versus the two-dimensional ones available through standard full-field digital mammography. This gives a more comprehensive and clear image for the radiologist to interpret, increases the early detection rate for breast cancer by up to 15%, and decreases the number of false positive findings by about 25%.

Physician referrals are needed for patients to schedule a digital breast tomosynthesis exam. For more information, call (401) 274-1122, ext. 1248.

DOTmed: Any final thoughts?
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; a Center of Excellence for Reproductive Resource Services; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group.

You Must Be Logged In To Post A Comment